AI assistant
Sending…
SOLESENCE, INC. — Director's Dealing 2018
Mar 28, 2018
33563_dirs_2018-03-28_8727a52c-41f0-4999-aaff-4d0089800fc6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2018-03-26
Reporting Person: ESCOBAR JAIME (Chief Financial Officer)
More from SOLESENCE, INC.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 23
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Dec 2
Regulatory Filings
2025
Dec 1